Completed NA INTERVENTIONAL 1-arm NCT00762320

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets in HIV-Positive Children

Sponsor: Abbott

Updated 9 times since 2017 Last updated: Feb 5, 2014 Started: Oct 31, 2008 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00762320, this NA trial focuses on HIV Infections and remains completed. Sponsored by Abbott, it has been updated 9 times since 2008, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Dec 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
Phoenix Children's Hospital

Data source: Phoenix Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Phoenix, United States